Signal Patients increasingly ask doctors for a named GLP-1 brand

Summary

PwC reports, on the account of an executive at the GLP-1 manufacturer Novo Nordisk, that patients are increasingly arriving at consultations asking for treatment or even for a specific brand, pulling the category through the healthcare system from the consumer side.